Table 1.
NBCA.
| Characteristics and results | Patients (n=63) |
|---|---|
| Age (mean, range, SD) | 62.7 (21-82, 12) |
| Barrow classification (n, %) | |
| B | 14 (22.2) |
| C | 6 (9.5) |
| D | 43 (68.2) |
| Venous cortical reflux (n, %) | 18 (28.5) |
| Side of the fistula (n, %) | |
| Right | 28 (44.4) |
| Left | 28 (44.4) |
| Bilateral | 7 (11.1) |
| Transvenous embolization (n, %) | 60 (95.2) |
| Arterial embolization (n, %) | 2 (3.1) |
| Combined arterial + venous embolization (n, %) | 1 (1.5) |
| Ipsilateral access | 52 (82.5) |
| Contralateral access | 5 (7.9) |
| Bilateral access | 4 (6.3) |
| Transvenous routes to the fistula (n, %) | 61 (96.8) |
| Inferior petrosal sinus | 41 (65) |
| Recanalization of occluded inferior petrosal sinus (n, %) | 13 (20.6) |
| Facial vein | 13 (20.6) |
| Superior petrosal sinus | 2 (3.1) |
| Direct puncture of cavernous sinus | 5 (7.9) |
| Embolic materials (n, %) | |
| Coils | 33 (52.3) |
| NBCA | 3 (4.7) |
| Onyx | 5 (7.9) |
| Coils + NBCA | 6 (9.5) |
| Coils + Onyx | 16 (25.4) |
| Treatment related complications (n, %) | 2 (3.1) |
| Complete immediate angiographic occlusion (n, %) | 53 (84.1) |
| Complete angiographic occlusion at the 6-month follow-up (n, %) | 53/53 (100) |
| Recurrence during 6-month follow-up (n, %) | 1 (1.5) |
NCBA: N-butyl cyanoacrylate.